UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 179

Sortiert nach

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Annals of oncology, 2018-10, Vol.29, p.viii729-viii729

2018

Volltextzugriff (PDF)

Association between treatment effects on disease progression end points and overall survival in clinical studies of patients with metastatic renal cell carcinoma

British journal of cancer, 2012-09, Vol.107 (7), p.1059-1068

2012

Volltextzugriff (PDF)

Pembrolizumab for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of treatment options from the phase III KEYNOTE-040 trial

Annals of oncology, 2018-10, Vol.29, p.viii373-viii374

2018

Volltextzugriff (PDF)

A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck

Annals of oncology, 2013-03, Vol.24 (3), p.761-769

2013

Volltextzugriff (PDF)

ZRF4, a combi-molecule with increased efficacy as compared with the individual components in chronic lymphocytic leukemia lymphocytes in vitro

Leukemia, 2011-09, Vol.25 (9), p.1512-1516

2011

Volltextzugriff (PDF)

OC-021: Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN

Radiotherapy and oncology, 2017-03, Vol.122, p.14-14

2017

Volltextzugriff (PDF)

Phase 1-2 Study Evaluating Reduced Radiation Volume and Dosage Using Comprehensive Tomotherapy and Concurrent Chemotherapy for Oropharyngeal Carcinoma

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S510-S510

2014

Volltextzugriff (PDF)

Review of guidelines on the treatment of metastatic renal cell carcinoma

Current oncology (Toronto), 2009-05, Vol.16 Suppl 1 (11), p.S67-70

Soulières, D

2009

Volltextzugriff (PDF)

KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies

Current oncology (Toronto), 2010-07, Vol.17 Suppl 1 (11), p.S31-40

2010

Volltextzugriff (PDF)

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence

Oral oncology, 2023-12, Vol.147, p.106587-106587, Article 106587

2023

Volltextzugriff (PDF)

The Role of PET-CT After Chemoradiation in Partially Regressed Nodal Disease

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S530-S530

2012

Volltextzugriff (PDF)

Systemic Inflammatory Markers Can Predictive Response in Radiation Therapy to the Prostate

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e914-e914

2020

Volltextzugriff (PDF)

PO-126: Adaptive Radiation Therapy in HPV Positive Oropharyngeal Carcinoma: A Preliminary Toxicity Report

Radiotherapy and oncology, 2013-02, Vol.106, p.S54-S54

2013

Volltextzugriff (PDF)

A Comparison of Simultaneously Integrated Boost using Intensity-modulated Radiation Therapy and Conventional Radiation Therapy in the Setting of Concomitant Carboplatin and 5-Fluorouracil for Locally Advanced Oropharyngeal Carcinoma

International journal of radiation oncology, biology, physics, 2009-11, Vol.75 (3), p.S33-S33

2009

Volltextzugriff (PDF)

Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting

Current oncology (Toronto), 2018-12, Vol.25 (6), p.e576-584

2018

Volltextzugriff (PDF)

Dynamic Prediction of Toxicities in Head and Neck Cancer Radiotherapy by 3D Convolutional Neural Network Using Daily Cone-Beam CTs

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.S55-S55

2023

Volltextzugriff (PDF)

Stereotactic Boost and Short-Course Radiotherapy for p16-Associated Oropharynx Cancer (SHORT-OPC): First Planned Interim Safety Analysis from a Randomized Phase II Trial

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e564-e565

2023

Volltextzugriff (PDF)

Renal cell carcinoma in the Canadian Indigenous population

Current oncology (Toronto), 2019-06, Vol.26 (3), p.e367-371

2019

Volltextzugriff (PDF)

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2019-03, Vol.380 (12), p.1116-1127

2019

Volltextzugriff (PDF)

HPV Prevalence and Prognostic Value in a Prospective Cohort of 255 Patients with Locally Advanced HNSCC: A Single-Centre Experience

International Journal of Otolaryngology, 2013-01, Vol.2013, p.437815-9

2013

Volltextzugriff (PDF)

Is Concurrent Chemotherapy and Radiotherapy in Elderly Head and Neck Patients a Reasonable and Safe Approach? The Notre-Dame Hospital Experience

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S407-S407

2009

Volltextzugriff (PDF)

Role of Neck Dissection following Chemoradiation in Patients with Advanced Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S177-S178

2009

Volltextzugriff (PDF)

Analysis of efficacy outcomes based on programmed death ligand 1 (PD-L1) scoring techniques in patients with head and neck squamous cell carcinoma (HNSCC) from KEYNOTE-040

Annals of oncology, 2019-10, Vol.30, p.v452-v453

2019

Volltextzugriff (PDF)

1115PD - Analysis of efficacy outcomes based on programmed death ligand 1 (PD-L1) scoring techniques in patients with head and neck squamous cell carcinoma (HNSCC) from KEYNOTE-040

Annals of oncology, 2019-10, Vol.30, p.v452-v453

2019

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(163)
Mit Volltextzugriff
(174)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Humans
(41)
Oncology
(39)
Male
(32)
Female
(30)
Middle Aged
(26)
Aged
(25)
Hematology, Oncology And Palliative Medicine
(23)
Adult
(22)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Tumors
(13)
Aged, 80 And Over
(12)
Chemotherapy
(11)
Radiology
(11)
Treatment Outcome
(10)
Cancer Therapies
(9)
Metastasis
(9)
Prognosis
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Association between treatment effects on disease progression end points and overall survival in clinical studies of patients with metastatic renal cell carcinoma

Pembrolizumab for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of treatment options from the phase III KEYNOTE-040 trial

A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck

ZRF4, a combi-molecule with increased efficacy as compared with the individual components in chronic lymphocytic leukemia lymphocytes in vitro

OC-021: Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN

Phase 1-2 Study Evaluating Reduced Radiation Volume and Dosage Using Comprehensive Tomotherapy and Concurrent Chemotherapy for Oropharyngeal Carcinoma

Review of guidelines on the treatment of metastatic renal cell carcinoma

KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence

The Role of PET-CT After Chemoradiation in Partially Regressed Nodal Disease

Systemic Inflammatory Markers Can Predictive Response in Radiation Therapy to the Prostate

PO-126: Adaptive Radiation Therapy in HPV Positive Oropharyngeal Carcinoma: A Preliminary Toxicity Report

A Comparison of Simultaneously Integrated Boost using Intensity-modulated Radiation Therapy and Conventional Radiation Therapy in the Setting of Concomitant Carboplatin and 5-Fluorouracil for Locally Advanced Oropharyngeal Carcinoma

Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Dynamic Prediction of Toxicities in Head and Neck Cancer Radiotherapy by 3D Convolutional Neural Network Using Daily Cone-Beam CTs

Stereotactic Boost and Short-Course Radiotherapy for p16-Associated Oropharynx Cancer (SHORT-OPC): First Planned Interim Safety Analysis from a Randomized Phase II Trial

Renal cell carcinoma in the Canadian Indigenous population

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

HPV Prevalence and Prognostic Value in a Prospective Cohort of 255 Patients with Locally Advanced HNSCC: A Single-Centre Experience

Is Concurrent Chemotherapy and Radiotherapy in Elderly Head and Neck Patients a Reasonable and Safe Approach? The Notre-Dame Hospital Experience

Role of Neck Dissection following Chemoradiation in Patients with Advanced Head and Neck Cancer

Analysis of efficacy outcomes based on programmed death ligand 1 (PD-L1) scoring techniques in patients with head and neck squamous cell carcinoma (HNSCC) from KEYNOTE-040

1115PD - Analysis of efficacy outcomes based on programmed death ligand 1 (PD-L1) scoring techniques in patients with head and neck squamous cell carcinoma (HNSCC) from KEYNOTE-040

Suchergebnisse filtern